Loading clinical trials...
Loading clinical trials...
To evaluate the role of 3 cycles of irinotecan and cisplatin for patients with limited-stage small-cell lung cancer who received one course of etoposide and cisplatin plus concurrent accelerated hyper...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Haruhiko Fukuda
Collaborators
NCT02016872 · Non-Small-Cell-Lung Cancer (NSCLC)
NCT00191763 · Carcinoma, Non-Small-Cell-Lung Cancer
Aichi Cancer Center Hospital
Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi-ken
Aichi Cancer Center,Aichi Hospital
Okazaki,Kake-machi,Kuriyado,18, Aichi-ken
National Cancer Center Hospital East
Kashiwa-shi,Kashiwanoha,6-5-1, Chiba
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions